Cargando…
FGFR1–4 RNA-Based Gene Alteration and Expression Analysis in Squamous Non-Small Cell Lung Cancer
While fibroblast growth factor receptors (FGFRs) are involved in several biological pathways and FGFR inhibitors may be useful in the treatment of squamous non-small cell lung cancer (Sq-NSCLC), FGFR aberrations are not well characterized in Sq-NSCLC. We comprehensively evaluated FGFR expression, fu...
Autores principales: | Moes-Sosnowska, Joanna, Skupinska, Monika, Lechowicz, Urszula, Szczepulska-Wojcik, Ewa, Skronska, Paulina, Rozy, Adriana, Stepniewska, Aneta, Langfort, Renata, Rudzinski, Piotr, Orlowski, Tadeusz, Popiel, Delfina, Stanczak, Aleksandra, Wieczorek, Maciej, Chorostowska-Wynimko, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505002/ https://www.ncbi.nlm.nih.gov/pubmed/36142417 http://dx.doi.org/10.3390/ijms231810506 |
Ejemplares similares
-
Fibroblast Growth Factor Receptor 1-4 Genetic Aberrations as Clinically Relevant Biomarkers in Squamous Cell Lung Cancer
por: Moes-Sosnowska, Joanna, et al.
Publicado: (2022) -
Cryptogenic organizing pneumonia—Results of treatment with clarithromycin versus corticosteroids—Observational study
por: Radzikowska, Elżbieta, et al.
Publicado: (2017) -
Post-Translational Modifications of Circulating Alpha-1-Antitrypsin Protein
por: Lechowicz, Urszula, et al.
Publicado: (2020) -
The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients
por: Szpechcinski, Adam, et al.
Publicado: (2019) -
Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer
por: Chorostowska-Wynimko, J, et al.
Publicado: (2009)